{"id":"https://openalex.org/W2056654536","doi":"https://doi.org/10.1111/bcp.12375","title":"Response to letter regarding article \u2018Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis\u2019","display_name":"Response to letter regarding article \u2018Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis\u2019","publication_year":2014,"publication_date":"2014-03-11","ids":{"openalex":"https://openalex.org/W2056654536","doi":"https://doi.org/10.1111/bcp.12375","mag":"2056654536","pmid":"https://pubmed.ncbi.nlm.nih.gov/24611979","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4239987"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.12375","doi":"https://doi.org/10.1111/bcp.12375","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.12375","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4239987","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034985450","display_name":"Anna M. Brusch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802692842","display_name":"Fremantle Hospital","ror":"https://ror.org/03yxgmm62","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800882159","https://openalex.org/I2802692842","https://openalex.org/I4388446375","https://openalex.org/I4388482742"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Anna M. Brusch","raw_affiliation_strings":["Department of Clinical Immunology, Fremantle Hospital, Fremantle, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, Fremantle Hospital, Fremantle, WA, Australia","institution_ids":["https://openalex.org/I2802692842"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088157909","display_name":"Russell C. Clarke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802220196","display_name":"Sir Charles Gairdner Hospital","ror":"https://ror.org/01hhqsm59","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800882159","https://openalex.org/I2802220196","https://openalex.org/I4210133657","https://openalex.org/I4396570646"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Russell C. Clarke","raw_affiliation_strings":["Sir Charles Gairdner Hospital; Nedlands WA Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sir Charles Gairdner Hospital; Nedlands WA Australia","institution_ids":["https://openalex.org/I2802220196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024220515","display_name":"Peter R. Platt","orcid":"https://orcid.org/0000-0001-5934-827X","observed_orcids":["https://orcid.org/0000-0001-5934-827X"]},"institutions":[{"id":"https://openalex.org/I2802220196","display_name":"Sir Charles Gairdner Hospital","ror":"https://ror.org/01hhqsm59","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800882159","https://openalex.org/I2802220196","https://openalex.org/I4210133657","https://openalex.org/I4396570646"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Peter R. Platt","raw_affiliation_strings":["Sir Charles Gairdner Hospital; Nedlands WA Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sir Charles Gairdner Hospital; Nedlands WA Australia","institution_ids":["https://openalex.org/I2802220196"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080985934","display_name":"Elizabeth Jane Phillips","orcid":"https://orcid.org/0000-0002-7623-3383","observed_orcids":["https://orcid.org/0000-0002-7623-3383"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Elizabeth Phillips","raw_affiliation_strings":["Infectious Diseases/Clinical Pharmacology Vanderbilt University Nashville TN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases/Clinical Pharmacology Vanderbilt University Nashville TN USA","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5080985934"],"corresponding_institution_ids":["https://openalex.org/I200719446"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"4","first_page":"931","last_page":"932"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9315999746322632,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9315999746322632,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10634","display_name":"Food Allergy and Anaphylaxis Research","score":0.02239999920129776,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.01549999974668026,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pholcodine","display_name":"pholcodine","score":0.8360000252723694},{"id":"https://openalex.org/keywords/drug-induced-anaphylaxis","display_name":"drug-induced anaphylaxis","score":0.968999981880188},{"id":"https://openalex.org/keywords/skin-testing","display_name":"skin testing","score":0.7429999709129333},{"id":"https://openalex.org/keywords/specific-ige","display_name":"specific IgE","score":0.9879999756813049},{"id":"https://openalex.org/keywords/basophil-activation-test","display_name":"basophil activation test","score":0.875},{"id":"https://openalex.org/keywords/opioid-analgesics","display_name":"opioid analgesics","score":0.5649999976158142},{"id":"https://openalex.org/keywords/drug-sensitization","display_name":"drug sensitization","score":0.42500001192092896},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.5799999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8319908380508423},{"id":"https://openalex.org/C2775933838","wikidata":"https://www.wikidata.org/wiki/Q168800","display_name":"Anaphylaxis","level":3,"score":0.6869776248931885},{"id":"https://openalex.org/C2910841738","wikidata":"https://www.wikidata.org/wiki/Q3286619","display_name":"Neuromuscular Blocking Agents","level":2,"score":0.6491875648498535},{"id":"https://openalex.org/C2776217527","wikidata":"https://www.wikidata.org/wiki/Q944828","display_name":"Sensitization","level":2,"score":0.5830280780792236},{"id":"https://openalex.org/C110586980","wikidata":"https://www.wikidata.org/wiki/Q4168588","display_name":"Provocation test","level":3,"score":0.5555176734924316},{"id":"https://openalex.org/C2777866328","wikidata":"https://www.wikidata.org/wiki/Q174723","display_name":"Codeine","level":3,"score":0.5006008148193359},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4969985783100128},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.4672303795814514},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.44452592730522156},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.43850481510162354},{"id":"https://openalex.org/C2779060952","wikidata":"https://www.wikidata.org/wiki/Q2068896","display_name":"Drug allergy","level":3,"score":0.4313226342201233},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.40657687187194824},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3310500383377075},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32647061347961426},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27272748947143555},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12873539328575134},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1010371744632721},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000485","descriptor_name":"Allergens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000707","descriptor_name":"Anaphylaxis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D003061","descriptor_name":"Codeine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004342","descriptor_name":"Drug Hypersensitivity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009466","descriptor_name":"Neuromuscular Blocking Agents","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D064751","descriptor_name":"Ammonium Compounds","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1111/bcp.12375","doi":"https://doi.org/10.1111/bcp.12375","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.12375","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4239987","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4239987","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:24611979","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24611979","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Letter"},{"id":"pmh:oai:alma.61MUN_INST:11136376540007891","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Response-to-letter-regarding-article-Exploring/991005544435907891","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"},{"id":"pmh:oai:researchrepository.murdoch.edu.au:38881","doi":null,"is_oa":false,"landing_page_url":"http://researchrepository.murdoch.edu.au/id/eprint/38881/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Brusch, A.M., Clarke, R.C., Platt, P.R. and Phillips, E. <http://researchrepository.murdoch.edu.au/view/author/Phillips, Elizabeth.html> (2014) Response to letter regarding article \u2018Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis\u2019. British Journal of Clinical Pharmacology, 78 (4). pp. 931-932.","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4239987","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4239987","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1491156270","https://openalex.org/W2026166564","https://openalex.org/W2080240719","https://openalex.org/W2104951854","https://openalex.org/W2148888994","https://openalex.org/W2168941148"],"related_works":["https://openalex.org/W2104951854","https://openalex.org/W4360830340","https://openalex.org/W4312814950","https://openalex.org/W2516076369","https://openalex.org/W2148888994","https://openalex.org/W4400642608","https://openalex.org/W2750756513","https://openalex.org/W2168941148","https://openalex.org/W4389473371","https://openalex.org/W4391068121"],"abstract_inverted_index":{"Uyttebroek":[0,235],"et":[1,236],"al.":[2,237],"1":[3,238],"raise":[4,479],"some":[5],"pertinent":[6],"questions":[7,481],"regarding":[8,216,482],"the":[9,16,30,38,47,83,92,142,172,192,203,225,272,277,281,306,344,353,369,383,403,417,423,438,446,457,460,483,493],"utility":[10,100],"of":[11,18,41,86,144,154,174,227,262,283,287,308,310,355,368,381,440,449,459,485],"various":[12,257],"testing":[13,95,129,229,279,296,300],"modalities":[14],"in":[15,57,91,108,122,132,147,185,202,219,305,324,352,505,514],"assessment":[17,32,307],"neuromuscular":[19],"blocking":[20],"agent":[21,40],"(NMBA)":[22],"hypersensitivity.":[23,357],"In":[24,44,152],"our":[25,155,187,441],"cases,":[26,156],"clinical":[27,54,87],"history":[28,125],"was":[29,56,136,160,181,189,444],"major":[31],"tool":[33],"for":[34,194,346],"identifying":[35],"pholcodine":[36,51,74,97,209,356,392,450,470,486,506],"as":[37,259,291],"inciting":[39],"anaphylaxis":[42,61,510],"2.":[43],"both":[45,148,186,220],"patients,":[46],"temporal":[48],"association":[49,207,448],"between":[50,208],"exposure":[52,210,451,497],"and":[53,62,105,126,171,176,211,230,297,327,338,402,434,452,455,471,475,488,498],"reaction":[55,146],"keeping":[58],"with":[59,249,256],"drug-induced":[60],"no":[63,302],"alternative":[64],"causes":[65,103],"were":[66,79,169,222,274],"identified.":[67],"The":[68,214,285,340],"positive":[69],"allergen-specific":[70,231],"IgE":[71,128,232,299],"levels":[72],"to":[73,81,96,119,141,162,242,294,348,350,387,422,431,469,500,516],"(ImmunoCAP":[75],"Phadia,":[76],"Uppsala,":[77],"Sweden)":[78],"used":[80,118],"substantiate":[82],"high":[84],"index":[85,150],"suspicion.":[88],"As":[89,234],"mentioned":[90],"article,":[93],"skin":[94,228,295],"has":[98],"limited":[99],"because":[101],"it":[102],"wheal":[104],"flare":[106],"reactions":[107,396,409,468],"normal":[109],"control":[110],"subjects.":[111],"While":[112],"drug":[113,244,312],"provocation":[114,254],"challenges":[115,255],"are":[116,130,268,317,335,361,385,410,473],"sometimes":[117],"confirm":[120],"allergy":[121,515],"situations":[123],"where":[124],"skin/allergen-specific":[127],"ambiguous,":[131],"this":[133,135,476],"circumstance":[134],"not":[137,246,269,319,512],"felt":[138],"appropriate,":[139],"owing":[140],"severity":[143],"systemic":[145],"patients'":[149],"events.":[151],"one":[153],"a":[157,243,260,501],"tramadol":[158],"challenge":[159],"performed":[161],"give":[163],"additional":[164,428],"options":[165],"if":[166],"opiate":[167],"analgesics":[168],"required,":[170],"avoidance":[173],"codeine":[175,413],"its":[177],"active":[178,424],"metabolite":[179,425],"morphine":[180,472],"recommended.":[182],"Subsequent":[183],"evaluation":[184],"patients":[188,221,384],"targeted":[190],"toward":[191],"potential":[193,345,429,432,447],"NMBA":[195,212,217,349,453,489,509],"hypersensitivity":[196,395,467],"given":[197],"previous":[198],"studies":[199,360,462],"3-6,":[200],"presented":[201,342],"review,":[204],"suggesting":[205],"an":[206,292,364,398],"anaphylaxis.":[213,490],"recommendations":[215,273],"use":[218],"based":[223],"on":[224,276,445],"outcome":[226],"testing.":[233],"allude":[239],"to,":[240],"sensitization":[241,347,487,499],"does":[245,477],"always":[247],"equate":[248],"clinically":[250],"meaningful":[251],"allergy.":[252,313],"However,":[253,314,437],"NMBAs,":[258],"means":[261],"demonstrating":[263],"patient":[264,366,435],"tolerance":[265],"or":[266,321],"allergy,":[267,454],"feasible.":[270],"Thus,":[271],"made":[275],"available":[278,323],"at":[280,363],"time":[282],"assessment.":[284],"development":[286],"basophil":[288],"activation":[289],"tests":[290,316],"adjunct":[293],"specific":[298,404],"will":[301],"doubt":[303],"help":[304],"cases":[309,334,341],"suspected":[311],"these":[315],"currently":[318],"validated":[320],"routinely":[322],"most":[325],"centres,":[326],"sensitivity":[328],"may":[329],"be":[330],"lacking":[331],"even":[332],"when":[333],"carefully":[336],"phenotyped":[337],"selected.":[339],"demonstrate":[343],"occur":[351],"context":[354],"These":[358],"case":[359,461],"reflective,":[362],"individual":[365],"level,":[367],"population-based":[370],"evidence":[371],"cited":[372],"previously":[373],"3,":[374],"5,":[375],"6.":[376],"We":[377],"agree":[378],"that":[379],"consideration":[380],"whether":[382],"able":[386],"tolerate":[388],"opiates":[389],"following":[390],"true":[391],"immediate":[393],"(IgE)":[394],"is":[397,414],"important":[399,480],"practical":[400],"concern,":[401],"haptenated":[405],"products":[406],"mediating":[407],"such":[408],"unknown.":[411],"Indeed,":[412],"metabolized":[415],"by":[416],"genetically":[418],"polymorphic":[419],"isoform":[420],"CYP2D6":[421],"morphine,":[426],"adding":[427],"variability":[430],"cross-reactivity":[433],"tolerance.":[436],"focus":[439],"article":[442],"2":[443],"thus,":[456],"presentation":[458],"reflects":[463],"this.":[464],"Immunoglobulin":[465],"E-mediated":[466],"rare,":[474],"indeed":[478],"pathogenesis":[484],"At":[491],"present,":[492],"mechanisms":[494],"underlying":[495],"why":[496],"substituted":[502,521],"ammonium":[503,522],"ion":[504],"can":[507],"prime":[508],"but":[511],"result":[513],"all":[517],"compounds":[518],"containing":[519],"similar":[520],"ions":[523],"remain":[524],"unresolved.":[525]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}